Nevertheless, there is a need to perform more studies focused on evaluating clinical samples derived from different stages of cancer to determine the potential role of syntenin-1 as an early prognostic biomarker of invasion and metastasis in all those cancers its overexpression has been reported. Here, SDCBP is linked to cancer.